Soumya D, Srilatha B. Late stage complications of diabetes and insulin resistance. J Diabetes Metab. 2011;2:1000167. https://doi.org/10.4172/2155-6156.1000167.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. https://doi.org/10.1016/j.diabres.2019.107843.
Rehman A, Saeed A, Kanwal R, Ahmad S, Changazi SH. Therapeutic effect of sunflower seeds and flax seeds on diabetes. Cureus. 2021;13:e17256. https://doi.org/10.7759/cureus.17256.
Article PubMed PubMed Central Google Scholar
Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17:20–33. https://doi.org/10.1016/j.cmet.2012.11.012.
CAS Article PubMed PubMed Central Google Scholar
Stolf AM, Cardoso CC, Acco A. Effects of silymarin on diabetes mellitus complications: a review. Phytother Res. 2017;31:366–74. https://doi.org/10.1002/ptr.5768.
Ren B, Qin W, Wu F, Wang S, Pan C, Wang L, et al. Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats. Eur J Pharm. 2016;773:13–23. https://doi.org/10.1016/j.ejphar.2016.01.002.
Bai L, Li X, He L, Zheng Y, Lu H, Li J, et al. Antidiabetic potential of flavonoids from traditional Chinese medicine: a review. Am J Chin Med. 2019;47:933–57. https://doi.org/10.1142/S0192415X19500496.
CAS Article PubMed Google Scholar
Mirhoseini MBA, Rafieian-Kopaei M. Medicinal plants, diabetes mellitus and urgent needs. Herb Med Pharm. 2013;2:53–4.
Sharma A, Ghani A, Sak K, Tuli HS, Sharma AK, Setzer WN, et al. Probing into therapeutic anti-cancer potential of apigenin: recent trends and future directions. Recent Pat Inflamm Allergy Drug Disco. 2019;13:124–33. https://doi.org/10.2174/1872213X13666190816160240.
Salehi B, Venditti A, Sharifi-Rad M, Kregiel D, Sharifi-Rad J, Durazzo A, et al. The therapeutic potential of apigenin. Int J Mol Sci. 2019;20. https://doi.org/10.3390/ijms20061305.
Hostetler GL, Ralston RA, Schwartz SJ. Flavones: food sources, bioavailability, metabolism, and bioactivity. Adv Nutr. 2017;8:423–35. https://doi.org/10.3945/an.116.012948.
CAS Article PubMed PubMed Central Google Scholar
Nozhat Z, Heydarzadeh S, Memariani Z, Ahmadi A. Chemoprotective and chemosensitizing effects of apigenin on cancer therapy. Cancer Cell Int. 2021;21:574. https://doi.org/10.1186/s12935-021-02282-3.
CAS Article PubMed PubMed Central Google Scholar
Panda S, Kar A. Apigenin (4’,5,7-trihydroxyflavone) regulates hyperglycaemia, thyroid dysfunction and lipid peroxidation in alloxan-induced diabetic mice. J Pharm Pharmacol. 2007;59:1543–8. https://doi.org/10.1211/jpp.59.11.0012.
CAS Article PubMed Google Scholar
Lin CH, Chang CY, Lee KR, Lin HJ, Chen TH, Wan L. Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway. BMC Cancer. 2015;15:958. https://doi.org/10.1186/s12885-015-1965-7.
CAS Article PubMed PubMed Central Google Scholar
Fidelis QC, Faraone I, Russo D, Aragão Catunda-Jr FE, Vignola L, de Carvalho MG, et al. Chemical and biological insights of Ouratea hexasperma (A. St.-Hil.) Baill.: a source of bioactive compounds with multifunctional properties. Nat Prod Res. 2019;33:1500–3. https://doi.org/10.1080/14786419.2017.1419227.
CAS Article PubMed Google Scholar
DeRango-Adem EF, Blay J. Does oral apigenin have real potential for a therapeutic effect in the context of human gastrointestinal and other cancers. Front Pharmacol. 2021;12:681477. https://doi.org/10.3389/fphar.2021.681477.
CAS Article PubMed PubMed Central Google Scholar
Lim R, Barker G, Wall CA, Lappas M. Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium. Mol Hum Reprod. 2013;19:451–62. https://doi.org/10.1093/molehr/gat015.
CAS Article PubMed Google Scholar
Zhou Z, Zhang Y, Lin L, Zhou J. Apigenin suppresses the apoptosis of H9C2 rat cardiomyocytes subjected to myocardial ischemia‑reperfusion injury via upregulation of the PI3K/Akt pathway. Mol Med Rep. 2018;18:1560–70. https://doi.org/10.3892/mmr.2018.9115.
CAS Article PubMed PubMed Central Google Scholar
Perez-Moral N, Saha S, Philo M, Hart DJ, Winterbone MS, Hollands WJ, et al. Comparative bio-accessibility, bioavailability and bioequivalence of quercetin, apigenin, glucoraphanin and carotenoids from freeze-dried vegetables incorporated into a baked snack versus minimally processed vegetables: evidence from in vitro models and a human bioavailability study. J Funct foods. 2018;48:410–9. https://doi.org/10.1016/j.jff.2018.07.035.
CAS Article PubMed PubMed Central Google Scholar
Zafar A, Alruwaili NK, Imam SS, Hadal Alotaibi N, Alharbi KS, Afzal M, et al. Bioactive Apigenin loaded oral nano bilosomes: formulation optimization to preclinical assessment. Saudi Pharm J. 2021;29:269–79. https://doi.org/10.1016/j.jsps.2021.02.003.
CAS Article PubMed PubMed Central Google Scholar
Zhang J, Liu D, Huang Y, Gao Y, Qian S. Biopharmaceutics classification and intestinal absorption study of apigenin. Int J Pharm. 2012;436:311–7. https://doi.org/10.1016/j.ijpharm.2012.07.002.
CAS Article PubMed Google Scholar
Wong TY, Tsai MS, Hsu LC, Lin SW, Liang PH. Traversal of the blood-brain barrier by cleavable l-lysine conjugates of apigenin. J Agric Food Chem. 2018;66:8124–31. https://doi.org/10.1021/acs.jafc.8b01187.
CAS Article PubMed Google Scholar
Tang D, Chen K, Huang L, Li J. Pharmacokinetic properties and drug interactions of apigenin, a natural flavone. Expert Opin Drug Metab Toxicol. 2017;13:323–30. https://doi.org/10.1080/17425255.2017.1251903.
CAS Article PubMed Google Scholar
Jung UJ, Cho YY, Choi MS. Apigenin ameliorates dyslipidemia, hepatic steatosis and insulin resistance by modulating metabolic and transcriptional profiles in the liver of high-fat diet-induced obese mice. Nutrients. 2016;8. https://doi.org/10.3390/nu8050305.
Pan G, Zhao L, Xiao N, Yang K, Ma Y, Zhao X, et al. Total synthesis of 8-(6″-umbelliferyl)-apigenin and its analogs as anti-diabetic reagents. Eur J Med Chem. 2016;122:674–83. https://doi.org/10.1016/j.ejmech.2016.07.015.
CAS Article PubMed Google Scholar
Franke K, Porzel A, Schmidt J. Flavone-coumarin hybrids from Gnidia socotrana. Phytochemistry. 2002;61:873–8. https://doi.org/10.1016/s0031-9422(02)00358-8.
CAS Article PubMed Google Scholar
Sun H, Song X, Tao Y, Li M, Yang K, Zheng H, et al. Synthesis & α-glucosidase inhibitory & glucose consumption-promoting activities of flavonoid-coumarin hybrids. Future Med Chem. 2018;10:1055–66. https://doi.org/10.4155/fmc-2017-0293.
CAS Article PubMed Google Scholar
Su ZR, Fan SY, Shi WG, Zhong BH. Discovery of xanthine oxidase inhibitors and/or alpha-glucosidase inhibitors by carboxyalkyl derivatization based on the flavonoid of apigenin. Bioorg Med Chem Lett. 2015;25:2778–81. https://doi.org/10.1016/j.bmcl.2015.05.016.
CAS Article PubMed Google Scholar
Hakamata W, Nakanishi I, Masuda Y, Shimizu T, Higuchi H, Nakamura Y, et al. Planar catechin analogues with alkyl side chains: a potent antioxidant and an alpha-glucosidase inhibitor. J Am Chem Soc. 2006;128:6524–5. https://doi.org/10.1021/ja057763c.
CAS Article PubMed Google Scholar
Cheng N, Yi W-B, Wang Q-Q, Peng S-M, Zou X-Q. Synthesis and α-glucosidase inhibitory activity of chrysin, diosmetin, apigenin, and luteolin derivatives. Chin Chem Lett. 2014;25:1094–8. https://doi.org/10.1016/j.cclet.2014.05.021.
Wang QQ, Cheng N, Yi WB, Peng SM, Zou XQ. Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating apigenin and chrysin derivatives. Bioorg Med Chem. 2014;22:1515–21. https://doi.org/10.1016/j.bmc.2014.01.038.
CAS Article PubMed Google Scholar
Shukla S, Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm Res. 2010;27:962–78. https://doi.org/10.1007/s11095-010-0089-7.
CAS Article PubMed PubMed Central Google Scholar
Wang M, Firrman J, Liu L, Yam K. A review on flavonoid apigenin: dietary intake, ADME, antimicrobial effects, and interactions with human gut microbiota. BioMed Res Int. 2019;2019:7010467. https://doi.org/10.1155/2019/7010467.
CAS Article PubMed PubMed Central Google Scholar
Gurung RB, Kim EH, Oh TJ, Sohng JK. Enzymatic synthesis of apigenin glucosides by glucosyltransferase (YjiC) from Bacillus licheniformis DSM 13. Mol Cells. 2013;36:355–61. https://doi.org/10.1007/s10059-013-0164-0.
CAS Article PubMed PubMed Central Google Scholar
Vanegas KG, Larsen AB, Eichenberger M, Fischer D, Mortensen UH, Naesby M. Indirect and direct routes to C-glycosylated flavones in Saccharomyces cerevisiae. Microb Cell Factories. 2018;17:107. https://doi.org/10.1186/s12934-018-0967-y.
Liu HJ, Fan YL, Liao HH, Liu Y, Chen S, Ma ZG, et al. Apigenin alleviates STZ-induced diabetic cardiomyopathy. Mol Cell Biochem. 2017;428:9–21. https://doi.org/10.1007/s11010-016-2913-9.
CAS Article PubMed Google Scholar
Rauter AP, Martins A, Borges C, Mota-Filipe H, Pinto R, Sepodes B, et al. Antihyperglycaemic and protective effects of flavonoids on streptozotocin-induced diabetic rats. Phytother Res. 2010;24:S133–8. https://doi.org/10.1002/ptr.3017.
Al-Ishaq RK, Abotaleb M, Kubatka P, Kajo K, Büsselberg D. Flavonoids and their anti-diabetic effects: cellular mechanisms and effects to improve blood sugar levels. Biomolecules. 2019;9. https://doi.org/10.3390/biom9090430.
Babu PV, Liu D, Gilbert ER. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem. 2013;24:1777–89. https://doi.org/10.1016/j.jnutbio.2013.06.003.
留言 (0)